Ecuador vs Sur: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
Sur
97.0%
in 2024
Ecuador rank
1st
Sur rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- Sur
How they compare
Ecuador currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 3 times across 15 shared years of data; in 2005 it was Sur ahead.
Ecuador ranks 1st and Sur ranks 1st of 192 countries.
Sur has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.2% | 48.0% | 44.9% | Sur |
| 2010s | 21.7% | 54.9% | 33.2% | Sur |
| 2020s | 95.8% | 97.2% | 1.4% | Sur |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or Sur?
- Ecuador, at 100.0% against 97.0% in Sur as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and Sur?
- 3.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Sur?
- 15 years are reported by both, from 2005 to 2024.
- How do Ecuador and Sur rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and Sur ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.